HomeALDX • NASDAQ
Aldeyra Therapeutics Inc
add
$5.01
2.24%
After Hours:(0.00%)0.00
$5.01
Closed: Sep 18, 4:02:01 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.17M | -43.53% |
Net income | -9.77M | 42.03% |
Net profit margin | — | — |
Earnings per share | -0.16 | 42.86% |
EBITDA | -10.11M | 43.68% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.92M | 1.98% |
Total assets | 84.96M | -32.59% |
Total liabilities | 29.67M | 7.00% |
Total equity | 55.29M | — |
Shares outstanding | 59.90M | — |
Price to book | 5.33 | — |
Return on assets | -28.54% | — |
Return on capital | -33.89% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.77M | 42.03% |
Cash from operations | -8.56M | 35.31% |
Cash from investing | -554.13K | 96.96% |
Cash from financing | 0.00 | — |
Net change in cash | -9.11M | 71.05% |
Free cash flow | -6.27M | -171.20% |
Previous close
$4.90
Day range
$4.94 - $5.11
Year range
$1.14 - $7.19
Market cap
300.08M USD
Avg Volume
823.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
8
